Rebalix
Logo iSharesiShares · sheet of 5 September 2026
ETF sheet · official issuer and register data

iShares MSCI World ex-USA UCITS ETF

XUES · IE000ZDDJWZ5 · USD · domicile Ireland
Equity · Global · Large & mid capSFDR art. 6
Index tracked: MSCI World Ex US Net Index
TER
0.15%+ trans. 0.01%
Fund size
2 m EUR
Tracking difference
not computable
🇮🇹 tax rate
26.00%white list 0.01%
Replication
Physical
Income
Distributing
Launch 29 Apr 2026 · costs from the KID as of 2 Sept 2026 · 735 securities held · 1 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The Share Class is a share class of a Fund which aims to achieve a total return, taking into account both capital and income returns, which reflects the return of the MSCI World ex USA Index, the Fund’s benchmark index (“Index”). The Share Class, via the Fund, is passively managed and aims to invest so far as possible and practicable in the equity securities (e.g. shares) that make up the Index. The Index measures the performance of large and mid-capitalisation stocks across developed market countries excluding the United States which comply with MSCI's…

Performance since series start (in euro) — base 100

30 Apr 202631 Aug 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
109100108
High 109 (13 Aug 2026) · low 100 (5 May 2026) · last 108. Past performance is not indicative of future results.

Returns in euro

1 yearseries too young
3 yearsseries too young
5 yearsseries too young
10 yearsseries too young
Since series start+8.1%

Risk · 1 / 3 / 5 years

Volatility (ann.)
Max drawdown
Sharpe
Sortino
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · XUES · IE000ZDDJWZ51
RebalixXUES · IE000ZDDJWZ5 · sheet of 5 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years
Not honestly computable: index series not published by the issuer

Distributions · per share, in USD

last 12 months: 0.03 USD (0.56% of NAV) · 2 months of history: not a full year · last ex-date 16 Jul 2026
YearPaymentsTotal (USD)
202610.03

Holdings

Portfolio as declared by the issuer · 31 Aug 2026 · 735 securities · top-10 weight = 12.2%
Top holdingsWeight
ASML HOLDING2.6%
HSBC HOLDINGS PLC1.4%
ROCHE PS PAR AG1.2%
ROYAL BANK OF CANADA1.1%
NOVARTIS AG1.1%
SHELL PLC1.0%
NESTLE SA1.0%
ASTRAZENECA PLC1.0%
MITSUBISHI UFJ FINANCIAL GROUP1.0%
SIEMENS N AG0.9%
Countries (% of fund)
Japan20.8%United Kingdom12.7%Canada12.4%France8.6%Switzerland8.1%
Sectors (% of fund)
Financials27.9%Industrials17.7%Information Technology10.2%Health Care8.8%Consumer Discretionary7.8%

Listing venues

ESMA register (FIRDS) and official exchange lists
XUES · Euronext Amsterdam
+ 4 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.blackrock.com/it/investitori-privati/literature/kiid/eu-priips-ish
Factsheet · www.ishares.com/gls-download/literature/fact-sheet/xues-ishares-msci-w
Prospectus · www.blackrock.com/it/investitori-privati/literature/prospectus/ishares
The live sheet, always up to date
rebalix.com/en/etf/IE000ZDDJWZ5
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · XUES · IE000ZDDJWZ52